Charles River Laboratories International (CRL) Acquisitions (2009 - 2026)

Charles River Laboratories International has reported Acquisitions for 15 years, with the latest figure at $62.2 million in Q2 2026.

• On a quarterly basis, Acquisitions changed N/A year-over-year to $62.2 million in Q2 2026; TTM through Jun 2026 was $467.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $5.5 million, down 97.19% from the prior year.
• Acquisitions was $62.2 million for Q2 2026 at Charles River Laboratories International, down from $405.0 million in the prior quarter.
• The five-year high for Acquisitions was $405.0 million in Q1 2026, with the low at $5.5 million in Q2 2024.
• Average Acquisitions over 4 years is $158.5 million, with a median of $103.4 million recorded in 2023.
• The largest YoY upside for Acquisitions was 68.73% in 2022 against a maximum downside of 68.73% in 2022.
• Over 4 years, Acquisitions stood at $283.4 million in 2022, then tumbled by 48.97% to $144.6 million in 2023, then plunged by 96.21% to $5.5 million in 2024, then jumped by 1036.12% to $62.2 million in 2026.
• The last three Acquisitions figures came in at $62.2 million (Q2 2026), $405.0 million (Q1 2026), and $5.5 million (Q2 2024), per Business Quant data.